Core Viewpoint - The article highlights the significant contributions of Ma Dawei, a researcher at the Shanghai Institute of Organic Chemistry, in the field of synthetic biology and drug synthesis, emphasizing his dedication to finding optimal solutions for drug synthesis and his impact on the pharmaceutical industry [4][5][6]. Group 1: Research Contributions - Ma Dawei has made notable advancements in organic synthesis methods, particularly through the improvement of the Ullmann reaction, which addresses the challenge of constructing carbon-heteroatom bonds, widely applied in new drug development and material research [4][5]. - His team discovered a new amino acid molecule that significantly enhances the efficiency of the Ullmann reaction, marking a breakthrough in organic chemistry and establishing Ma as a prominent figure in the academic community [5][6]. - In 2015, Ma's team identified a new ligand, oxalyl diamine, leading to the "Ullmann-Ma" reaction, which has been extensively utilized in new drug development and material creation [6]. Group 2: Drug Synthesis and Cost Reduction - Ma Dawei emphasizes the importance of simplifying synthesis steps to reduce pharmaceutical costs, making medications more affordable for patients [7][8]. - His team developed a more efficient synthesis route for the complex anticancer drug, Qubeitidine, reducing the number of steps from over 40 to 26, thus positioning China as the largest global supplier of Qubeitidine raw materials [8]. - Throughout his career, Ma has completed over 70 complex active natural products' total synthesis, contributing significantly to the development of synthetic chemistry in China [8]. Group 3: Mentorship and Influence - Ma Dawei is recognized for his mentorship, guiding numerous students and researchers in their scientific endeavors, fostering a culture of inquiry and perseverance in research [9][10]. - His commitment to education is evident through initiatives like the "Future Scholarship," established with his award winnings to inspire young students to pursue scientific interests [9]. - The laboratory environment under Ma's guidance has become a hub for innovative research, with many young scientists continuing to explore molecular science [10].

Core Viewpoint - The article highlights the efforts of Chen Senhua and his research team at Sun Yat-sen University in exploring marine natural products for drug development, emphasizing the potential of marine resources to benefit human health and the challenges faced in this field [2][8][90]. Group 1: Research Focus and Achievements - Chen Senhua has dedicated his research to marine natural product chemistry and drug development, focusing on the entire chain from marine resources to active ingredients and drug research [8][90]. - The team has identified over 40,000 unique marine natural products globally, many of which possess novel chemical structures and pharmacological mechanisms [17][19]. - Successful examples of marine-derived drugs include several anti-cancer medications that have gained international recognition, such as the targeted anti-cancer drug derived from Caribbean sea tunicates [22][24]. Group 2: Drug Development Process - The process of developing new drugs from marine sources is likened to "finding a needle in a haystack," as it involves isolating thousands of strains to find useful candidates [25][50]. - The team has successfully discovered candidate drugs for anti-thrombotic and anti-tumor treatments, with one candidate, Isaridin E, showing significant improvement in models of arterial and venous thrombosis [29][52]. - Chen's team has built a compound library of over 3,000 marine natural products and a microbial strain library with over 10,000 strains, facilitating ongoing research and development [76]. Group 3: Challenges and Future Directions - The development of marine drugs faces significant challenges, including the lengthy and costly process of clinical trials, which often prevents many candidates from reaching the market [63][66]. - Chen emphasizes the importance of improving production efficiency and reducing costs to enhance the likelihood of successful drug development [66]. - Future research will leverage big data and AI technologies to analyze complex marine natural products more efficiently and accurately [78]. Group 4: Broader Applications and Collaborations - The research team's work extends beyond human pharmaceuticals to include agricultural applications, such as developing pesticides and promoting crop yields through marine resources [81][82]. - The concept of "new farmers" in the marine sector encompasses not only traditional farming but also advanced research and development in laboratories, utilizing high-tech equipment for drug discovery [88][90].